United States · FDA National Drug Code directory

Ciprofloxacin

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-1229_7030109d-5ce0-43f1-a5ed-16a3562acd40
Product NDC
71335-1229
Form
TABLET, COATED
Composition / generic term
Ciprofloxacin Tablets
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20190713
Source listing expiry
20261231

Source-listed ingredients

  • CIPROFLOXACIN HYDROCHLORIDE — 500 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 7 TABLET, COATED in 1 BOTTLE (71335-1229-0) · 71335-1229-0
  • 14 TABLET, COATED in 1 BOTTLE (71335-1229-1) · 71335-1229-1
  • 30 TABLET, COATED in 1 BOTTLE (71335-1229-2) · 71335-1229-2
  • 20 TABLET, COATED in 1 BOTTLE (71335-1229-3) · 71335-1229-3
  • 60 TABLET, COATED in 1 BOTTLE (71335-1229-4) · 71335-1229-4
  • 6 TABLET, COATED in 1 BOTTLE (71335-1229-5) · 71335-1229-5
  • 10 TABLET, COATED in 1 BOTTLE (71335-1229-6) · 71335-1229-6
  • 28 TABLET, COATED in 1 BOTTLE (71335-1229-7) · 71335-1229-7
  • 100 TABLET, COATED in 1 BOTTLE (71335-1229-8) · 71335-1229-8
  • 40 TABLET, COATED in 1 BOTTLE (71335-1229-9) · 71335-1229-9

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →